BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38128189)

  • 1. Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkers.
    Karimi B; Mokhtari K; Rozbahani H; Peymani M; Nabavi N; Entezari M; Rashidi M; Taheriazam A; Ghaedi K; Hashemi M
    Pathol Res Pract; 2024 Jan; 253():155014. PubMed ID: 38128189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer.
    Li Z; Zhou J; Gu L; Zhang B
    Sci Rep; 2022 Oct; 12(1):17787. PubMed ID: 36272991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cancer-related potential biomarkers based on lncRNA-pseudogene-mRNA competitive networks.
    Wu C; Wei Y; Zhu Y; Li K; Zhu Y; Zhao Y; Chang Z; Xu Y
    FEBS Lett; 2018 Mar; 592(6):973-986. PubMed ID: 29453881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of miRNAs and Pseudogenes in Cancer.
    Tutar L; Özgür A; Tutar Y
    Methods Mol Biol; 2018; 1699():45-66. PubMed ID: 29086367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
    Kishore C; Karunagaran D
    Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding RNA:RNA Regulatory Networks in Cancer.
    Chan JJ; Tay Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs.
    Chang G; Xie D; Hu J; Wu T; Cao K; Luo X
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer.
    Guo T; Li J; Zhang L; Hou W; Wang R; Zhang J; Gao P
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):31-48. PubMed ID: 30417217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
    Yue C; Ren Y; Ge H; Yan L; Xu Y; Wang G; Wu J
    J Cell Physiol; 2019 Dec; 234(12):23685-23694. PubMed ID: 31169303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response.
    Ghafouri-Fard S; Shoorei H; Dashti S; Branicki W; Taheri M
    J Cell Physiol; 2020 Dec; 235(12):9269-9290. PubMed ID: 32529678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs as potential biomarkers of gallbladder cancer.
    Lv Y; Yin W; Zhang Z
    Clin Transl Oncol; 2023 Jun; 25(6):1489-1511. PubMed ID: 36576705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
    Chen J; Lou W; Ding B; Wang X
    Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer.
    Lou W; Ding B; Zhong G; Du C; Fan W; Fu P
    Aging (Albany NY); 2019 Dec; 11(23):11416-11439. PubMed ID: 31794425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.
    Lv Y; Wang Y; Zhang Z
    Hum Cell; 2023 Jan; 36(1):76-97. PubMed ID: 36181662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.